Genea, Where babies come from
Location: Australia, New South Wales, Sydney
Employees: 201-500
Phone: +61 1300 361 795
Founded date: 1986
Investors 1
| Date | Name | Website |
| 24.08.2022 | Liverpool ... | liverpoolp... |
Mentions in press and media 6
| Date | Title | Description |
| 20.11.2025 | - | The lobby at GenPrime Fertility, Singapore — one of two newly opened clinics, where integrated fertility care, from consultation to treatment and recovery, comes together under one roof. GenPrime is part of Rhea Fertility, a global reproduc... |
| 06.11.2025 | Leading Fertility Specialist Associate Professor Gavin Sacks joins Genea | SYDNEY, Nov. 6, 2025 /PRNewswire/ -- Genea Fertility, Australia's pioneering fertility network, is pleased to announce the appointment of internationally renowned fertility specialist, Associate Professor Gavin Sacks, to its medical leaders... |
| 12.09.2024 | Genea Biomedx solidifies its exclusive partnership in Australia with Genea Fertility | SYDNEY, Sept. 12, 2024 /PRNewswire/ -- Genea Biomedx, which was once part of Genea Fertility, joined the Basecare Medical group in 2023 with the aim of distributing Basecare's assisted reproductive technology internationally. Previously an ... |
| 19.08.2020 | Premium Fertility Service Provider Genea Opens Clinic in Bangkok | SYDNEY, AUSTRALIA – Media OutReach – 19 August 2020 – Asian residents struggling to conceive will now have access to one of the world’s most premium providers of fertility services, especially mainland China that apparently has the world’s ... |
| 29.05.2015 | Johnson and Johnson accepts $2B offer for vascular medical device producer, Teva reaches settlement (Morning Read) | Otsuka Pharmaceutical Co Ltd lost a lawsuit challenging the U.S. Food and Drug Administration’s decision allowing other companies to make generic versions of the it’s antipsychotic drug, Abilify. Because the FDA typically grants years of ex... |
| - | Johnson and Johnson accepts $2B offer for vascular medical device producer, Teva reaches settlement (Morning Read) | TOP STORIES Johnson & Johnson (NYSE: JNJ) has accepted Cardinal Health‘s $2 billion offer to acquire vascular medical device producer, Cordis. Teva reached a $1.2 billion settlement with the Federal Trade Commission over claims that Cep... |